@article{48df956b4fac45899233d4242fb96179,
title = "Practice guidelines for therapeutic drug monitoring of vancomycin: A consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring",
keywords = "Guideline, MRSA, Therapeutic drug monitoring, Vancomycin",
author = "Kazuaki Matsumoto and Yoshio Takesue and Norio Ohmagari and Takahiro Mochizuki and Hiroshige Mikamo and Masafumi Seki and Shunji Takakura and Issei Tokimatsu and Yoshiko Takahashi and Kei Kasahara and Kenji Okada and Masahiro Igarashi and Masahiro Kobayashi and Yukihiro Hamada and Masao Kimura and Yoshifumi Nishi and Yusuke Tanigawara and Toshimi Kimura",
note = "Funding Information: Conflict of interest Yoshio Takesue has received a speaker{\textquoteright}s honorarium from Pfizer Japan Inc., Astellas Pharma, Shionogi & Co., Ltd., MSD KK, Taisho Toyama Pharmaceutical Co., Ltd., and Dai-nippon Sumitomo Pharma. Yoshio Takesue has received Grant support from Pfizer Japan Inc., Astellas Pharma, Shionogi & Co., Ltd., MSD KK, Taisho Toyama Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, and Dainippon Sumitomo Pharma. Norio Ohmagari has received speaker{\textquoteright}s honorarium from Pfizer Japan Inc., Shionogi & Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd. Masafumi Seki has received a speaker{\textquoteright}s honorarium from Pham. Corporations as follows: Astellas Inc., MSD Inc., Pfizer Japan Inc., Shionogi Inc., and Taisho Toyama Inc. Shunji Takakura has received speaker{\textquoteright}s honorarium from Pfizer Japan Inc., Astellas Pharma Inc. Yusuke Tanigawara is a consultant to Meiji Seika Pharma Co., Ltd. Toshimi Kimura has received a speaker{\textquoteright}s honorarium from Meiji Seika Pharma.",
year = "2013",
month = jun,
doi = "10.1007/s10156-013-0599-4",
language = "English",
volume = "19",
pages = "365--380",
journal = "Journal of Infection and Chemotherapy",
issn = "1341-321X",
publisher = "Elsevier BV",
number = "3",
}
